haloperidol has been researched along with Hematuria in 1 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Hematuria: Presence of blood in the urine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "BACKGROUND Rhabdomyolysis is a condition in which intracellular components are released into the blood and urine." | 5.72 | A Case of Exacerbation of Haloperidol-Induced Rhabdomyolysis Following the Onset of COVID-19. ( Hirose, N; Inoue, J; Ishii, J; Koshioka, S; Kunishima, H; Kurata, T; Matsuura, M; Nagumo, F; Sada, Y; Samura, M; Takada, K; Tanikawa, K; Uchida, M, 2022) |
| "BACKGROUND Rhabdomyolysis is a condition in which intracellular components are released into the blood and urine." | 1.72 | A Case of Exacerbation of Haloperidol-Induced Rhabdomyolysis Following the Onset of COVID-19. ( Hirose, N; Inoue, J; Ishii, J; Koshioka, S; Kunishima, H; Kurata, T; Matsuura, M; Nagumo, F; Sada, Y; Samura, M; Takada, K; Tanikawa, K; Uchida, M, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takada, K | 1 |
| Sada, Y | 1 |
| Samura, M | 1 |
| Matsuura, M | 1 |
| Hirose, N | 1 |
| Kurata, T | 1 |
| Nagumo, F | 1 |
| Ishii, J | 1 |
| Koshioka, S | 1 |
| Uchida, M | 1 |
| Inoue, J | 1 |
| Tanikawa, K | 1 |
| Kunishima, H | 1 |
1 other study available for haloperidol and Hematuria
| Article | Year |
|---|---|
A Case of Exacerbation of Haloperidol-Induced Rhabdomyolysis Following the Onset of COVID-19.
Topics: Acute Kidney Injury; COVID-19; Haloperidol; Hematuria; Humans; Male; Middle Aged; Rhabdomyolysis | 2022 |